Author

Chi‐Ren Shyu

ORCID 0000-0001-9197-9522Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Akhil SrivastavaiD· 1 shared Feng GaoiD· 1 shared Guangfu LiiD· 1 shared Jonathan B. MitchemiD· 1 shared Jussuf T. KaifiiD· 1 shared Kanve Nagaraj SuvileshiD· 1 shared Matthew A. CiorbaiD· 1 shared Mohamed GadelkarimiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akhil SrivastavaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 18, 2023

Patient-derived tumor organoids from resected non-small cell lung cancers for high-throughput response testing with approved and repurposed drugs

Kanve Nagaraj Suvilesh, Yariswamy Manjunath, Yulia I. Nussbaum…·Jussuf T. Kaifi

This study develops patient-derived tumor organoids from non-metastatic NSCLC tumors to test drug responses and identify chemoresistance mechanisms, finding 50% of organoids were chemo-resistant and could be sensitized by repurposed drugs.

DOI 10.1101/2023.10.18.562944

humanbulk RNA-seq

𝕏 PostBluesky